CurrentCardio
Get Weekly

Topic · page 15 of 28

Coronary disease & ACS

Acute and chronic coronary syndromes, MI, INOCA/ANOCA, revascularisation strategy, antithrombotic therapy after ACS/PCI, chest-pain diagnostics

Briefs 561–600 of 1,104 placed here, newest publication first

Briefs in Coronary disease & ACS

Newest publication first

  1. J Am Coll Cardiol

    Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus Burden: A Randomized Trial

    Randomised controlled trial

  2. N Engl J Med

    Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction

    Randomised controlled trial

  3. JACC Cardiovasc Imaging

    Prevalence and Prognostic Value of Incidentally Detected Coronary Artery Calcium Using Artificial Intelligence Among Individuals With Immune-Mediated Inflammatory Diseases

    Cohort study

  4. Eur Heart J

    Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial

    Randomised controlled trial

  5. Circulation

    The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study

    Mechanistic study

  6. J Am Coll Cardiol

    Drug-Coated Balloon Angioplasty vs Up-Front Stenting for De Novo CAD: 3-Year Follow-Up of REC-CAGEFREE I Trial

    Secondary analysis

  7. Eur J Prev Cardiol

    Long-term prognosis of unrecognized myocardial infarction in women and men from the general population: the Rotterdam Study

    Cohort study

  8. JACC Cardiovasc Interv

    Radiation Exposure to Operators in Coronary Procedures Between Left Distal and Right Conventional Radial Access

    Randomised controlled trial

  9. JACC Cardiovasc Interv

    Core Laboratory Comparison of Angiography-Derived Indexes of Microvascular Resistance vs Pressure-Wire IMR and Absolute Resistance

    Diagnostic or prognostic study

  10. Lancet

    Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial

    Randomised controlled trial

  11. Eur J Prev Cardiol

    Future myocardial infarction after an acute coronary syndrome and pharmacogenetic response to dalcetrapib

    Secondary analysis

  12. J Am Coll Cardiol

    Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position Statement

    Guideline or statement

  13. JACC Cardiovasc Interv

    Association Between Angiography-Derived Murray Law–Based Quantitative Flow Ratio and 1-Year Coronary Artery Bypass Graft Patency

    Cohort study

  14. JACC Cardiovasc Interv

    Intravascular Imaging vs Angiography Guidance for PCI of Severely Calcified Lesions: The ECLIPSE Trial

    Secondary analysis

  15. Eur J Prev Cardiol

    Exercise-based cardiac rehabilitation for coronary heart disease: the CaReMATCH individual participant data meta-analysis

    Meta-analysis

  16. JAMA

    Helicobacter pylori Screening After Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI SWEDEHEART Trial

    Randomised controlled trial

  17. Eur J Prev Cardiol

    Long-term impact of telemedicine for lipid control after an acute coronary syndrome

    Cohort study

  18. Eur J Prev Cardiol

    Association of neutrophil-to-lymphocyte ratio with clinical outcomes after percutaneous coronary intervention

    Cohort study

  19. JAMA Cardiol

    Noninvasive Anatomical and Functional Imaging for Hemodynamic Relevance in Right Coronary Artery Anomalies

    Diagnostic or prognostic study

  20. Nat Med

    Antibody-mediated LOX-1 inhibition in patients with residual inflammation after myocardial infarction: a randomized phase 2 trial

    Randomised controlled trial

  21. Circulation

    Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults

    Cohort study

  22. Circulation

    Post–Myocardial Infarction Psychological Distress: A Scientific Statement From the American Heart Association

    Guideline or statement

  23. JACC Cardiovasc Interv

    Drug-Coated Balloons in the European Registry of Chronic Total Occlusion: The ERCTO Registry

    Cohort study

  24. JACC Cardiovasc Interv

    Validation of Intravascular Ultrasound–Defined Optimal Stent Expansion Criteria for Favorable 1-Year Clinical Outcomes

    Meta-analysis

  25. J Am Coll Cardiol

    Trajectories of Angina After Initial Invasive vs Conservative Strategy for Chronic Coronary Disease

    Secondary analysis

  26. JACC Cardiovasc Interv

    5-Year Outcomes With a Novel Coronary Sirolimus-Eluting Bioresorbable Scaffold: The NeoVas Randomized Trial

    Randomised controlled trial

  27. Circulation

    Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA

    Secondary analysis

  28. Lancet

    Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial

    Randomised controlled trial

  29. N Engl J Med

    Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for Acute Coronary Syndrome

    Randomised controlled trial

  30. N Engl J Med

    Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction

    Randomised controlled trial

  31. N Engl J Med

    Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes

    Randomised controlled trial

  32. Lancet

    Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION–STEMI): a multicentre, non-inferiority, open-label, randomised trial

    Randomised controlled trial

  33. N Engl J Med

    Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation

    Randomised controlled trial

  34. J Am Coll Cardiol

    Computed Tomography Angiography or Standard Care After Left Main PCI?

    Randomised controlled trial

  35. Eur Heart J

    Reticulated platelets in coronary artery disease: a multidimensional approach unveils prothrombotic signalling and novel therapeutic targets

    Mechanistic study

  36. Eur Heart J

    Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trial

    Randomised controlled trial

  37. J Am Coll Cardiol

    Twice-Daily Clopidogrel vs Ticagrelor to Reduce Short-Term Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention: The TADCLOT Trial

    Randomised controlled trial

  38. N Engl J Med

    Beta-Blockers after Myocardial Infarction in Patients without Heart Failure

    Randomised controlled trial

  39. J Am Coll Cardiol

    Personalized or Standard Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: The PARTHENOPE Randomized Trial

    Randomised controlled trial

  40. N Engl J Med

    Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction

    Randomised controlled trial

All 1,104 Briefs in ExploreShowing Briefs 561–600 of 1,104, newest first